Objectives:

1. Understand difference between buprenorphine and morphine

2. Evaluate the efficiacy of buprenoprhine for treatment of NAS

3. Discuss the likelihood/indiciation for a practice change

 

Session date: 
Thursday, August 3, 2017 - 1:30pm to 3:00pm
Speaker Name: 
Elizabeth Boyle, DO
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.